Trials / Completed
CompletedNCT01625273
Supplementation of Infant Formula With Synbiotics
Supplementation of Infant Formula With the Synbiotics (Lactobacillus Paracasei Ssp. Paracasei Strain F19 and Fructo- and Galactooligosaccharides).
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 182 (actual)
- Sponsor
- Arla Foods · Industry
- Sex
- All
- Age
- 1 Day – 28 Days
- Healthy volunteers
- Accepted
Summary
The primary hypothesis is that Lactobacillus paracasei ssp. paracasei strain F19 in an infant formula containing FOS/GOS is safe and tolerable for use in infants from 0 to 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Lactobacillus paracasei paracasei strain F19 | Provided in an infant formula, 10\^8 CFU per day from 28 days to 6 months of infant age |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2016-03-01
- Completion
- 2016-04-01
- First posted
- 2012-06-21
- Last updated
- 2017-01-26
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT01625273. Inclusion in this directory is not an endorsement.